78 related articles for article (PubMed ID: 5084947)
1. Post-operative depression of tumour-directed cell-mediated immunity in patients with malignant disease.
Cochran AJ; Thomas CE; McKie RM; Spilg WG
J Pathol; 1972 Jul; 107(3):Pv. PubMed ID: 5084947
[No Abstract] [Full Text] [Related]
2. Postoperative depression of tumour-directed cell-mediated immunity in patients with malignant disease.
Cochran AJ; Spilg WG; Mackie RM; Thomas CE
Br Med J; 1972 Oct; 4(5832):67-70. PubMed ID: 5077468
[TBL] [Abstract][Full Text] [Related]
3. Cellular immunity to breast carcinoma and malignant melanoma.
Cochran AJ; Mackie RM; Thomas CE; Grant RM; Cameron-Mowat DE; Spilg WG
Br J Cancer Suppl; 1973 Aug; 1():77-82. PubMed ID: 4804293
[TBL] [Abstract][Full Text] [Related]
4. Tumor-directed cellular immunity in malignant melanoma and its modification by surgical treatment.
Cochran AJ; Thomas CE; Spilg WG; Grant RM; Cameron-Mowat DE; Mackie RM; Lindop G
Yale J Biol Med; 1973 Dec; 46(5):650-4. PubMed ID: 4779137
[No Abstract] [Full Text] [Related]
5. Cellular immunity to tumour factors in human breast carcinoma.
Evans DJ; Simpson G; Campos A; Burn JI
Br J Surg; 1972 Apr; 59(4):301. PubMed ID: 5020742
[No Abstract] [Full Text] [Related]
6. Cellular reaction to concanavalin A studied by the skin window method in healthy subjects and in patients with malignant tumors.
Kolár Z; Jansa P; Kovarík J; Skovránková H; Krcová I
Acta Univ Palacki Olomuc Fac Med; 1987; 117():73-80. PubMed ID: 2977713
[No Abstract] [Full Text] [Related]
7. [Circulating immune complexes in the serum of tumor patients].
Alvarez R; García Gómez A; Subiza JL; Domínguez J; Bootello A; Coll J
Rev Esp Oncol; 1982; 29(4):727-34. PubMed ID: 6927370
[TBL] [Abstract][Full Text] [Related]
8. Cell- and antibody-mediated immune reactions of patients to cultured cells of breast carcinoma.
Sinkovics JG; Reeves WJ; Cabiness JR
J Natl Cancer Inst; 1972 Apr; 48(4):1145-9. PubMed ID: 5023675
[No Abstract] [Full Text] [Related]
9. Evaluation of pre-existent immunity in patients with primary breast cancer: molecular and cellular assays to quantify antigen-specific T lymphocytes in peripheral blood mononuclear cells.
Rentzsch C; Kayser S; Stumm S; Watermann I; Walter S; Stevanoviç S; Wallwiener D; Gückel B
Clin Cancer Res; 2003 Oct; 9(12):4376-86. PubMed ID: 14555509
[TBL] [Abstract][Full Text] [Related]
10. Natural humoral immunity in patients with malignant disease.
Higuchi M; Gupta RK; Irie RF; Morton DL
J Clin Lab Immunol; 1980 Nov; 4(3):141-3. PubMed ID: 7193740
[TBL] [Abstract][Full Text] [Related]
11. Lymphocyte sensitivity and cellular immunity in neoplasia.
Faguet GB; Balcerzak SP; Lobuglio AF
Biomedicine; 1973 Feb; 19(2):43-7. PubMed ID: 4731978
[No Abstract] [Full Text] [Related]
12. Reactivity of serum-armed xenogeneic macrophages to breast cancer antigens.
Harris LF; Miller LL; Hickok DF
Cancer Res; 1982 Dec; 42(12):4985-90. PubMed ID: 7139603
[TBL] [Abstract][Full Text] [Related]
13. Demonstration of cell-mediated and humoral antibodies in patients with malignant breast and ovary-tumours.
Kitschke HJ; Krebs D
Acta Eur Fertil; 1973 Jun; 4(2):75-7. PubMed ID: 4784141
[No Abstract] [Full Text] [Related]
14. Cell-mediated immunity against malignant melanoma in monozygous twins.
Nagel GA; St Arneault G; Holland JF; Kirkpatrick D; Kirkpatrick R
Cancer Res; 1970 Jun; 30(6):1828-32. PubMed ID: 5466283
[No Abstract] [Full Text] [Related]
15. Depression, cortisol, and suppressed cell-mediated immunity in metastatic breast cancer.
Sephton SE; Dhabhar FS; Keuroghlian AS; Giese-Davis J; McEwen BS; Ionan AC; Spiegel D
Brain Behav Immun; 2009 Nov; 23(8):1148-55. PubMed ID: 19643176
[TBL] [Abstract][Full Text] [Related]
16. [Immune complex study of malignant neoplasm patients].
Bilynskiĭ BT; Fetsich TG
Vrach Delo; 1983 May; (5):85-7. PubMed ID: 6880177
[No Abstract] [Full Text] [Related]
17. Cell-mediated immunity in prostatic cancer.
Ablin RJ; Bhatti RA; Nagubadi S; Zamora S; Guinan PD
Clin Oncol; 1980 Sep; 6(3):253-64. PubMed ID: 7428203
[No Abstract] [Full Text] [Related]
18. [Immunosuppression: a paraneoplastic syndrome].
Nagel GA
Schweiz Med Wochenschr; 1971 Apr; 101(13):470-4. PubMed ID: 5283773
[No Abstract] [Full Text] [Related]
19. The role of CD146 (Mel-CAM) in biology and pathology.
Shih IM
J Pathol; 1999 Sep; 189(1):4-11. PubMed ID: 10451481
[TBL] [Abstract][Full Text] [Related]
20. Use of the antibody-dependent cellular cytotoxicity test to detect antibodies in sera of breast cancer patients.
Plain MJ; Whitehead RH; Jose DG
J Natl Cancer Inst; 1981 Apr; 66(4):619-24. PubMed ID: 7014964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
